IPCA Laboratories, a Mumbai-based drugmaker, witnessed a fall in share price on Monday after the company reported a drop in standalone net profit for the quarter ended September 2014.  During the quarter, the profit of the company declined 52.65% to Rs 613 million from Rs 1,294.50 million  in the same quarter last year.

Net sales for the quarter declined 7.81% to Rs 7,806 million, compared with Rs 8,467 million for the prior year period.

Shares of the company are trading at Rs 647.50, down Rs 13.8, or 2.09% at the Bombay Stock Exchange (BSE) on Monday at 1:59 p.m.

The scrip has touched an intra-day high of Rs 675.50 and low of Rs 636.65. The total volume of shares traded at the BSE is 168,467.